Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Caparrotta

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 30, 2024
<i>UMOD</i> Genotype-Blinded Trial of Ambulatory Blood Pressure Response to TorasemideLinsay McCallum, Stefanie Lip, Alex McConnachie, et al.
Plos Medicine|October 20, 2020
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control studyPaul M McKeigue, Amanda Weir, Jen Bishop, et al.
Diabetologia|January 12, 2019
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational studyStuart J McGurnaghan, Liam Brierley, Thomas M Caparrotta, et al.
BMC Medicine|February 22, 2021
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control studyPaul M McKeigue, Sharon Kennedy, Amanda Weir, et al.
Diabetologia|February 20, 2021
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetesAndreas Höhn, Anita Jeyam, Thomas M Caparrotta, et al.
Eclinicalmedicine|July 19, 2019
Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol OverdoseJanice M Pettie, Thomas M Caparrotta, Robert W Hunter, et al.
Diabetologia|October 7, 2021
Flash monitor initiation is associated with improvements in HbA<sub>1c</sub> levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational studyAnita Jeyam, Fraser W Gibb, John A McKnight, et al.
Diabetologia|June 9, 2021
Development and validation of a cardiovascular risk prediction model in type 1 diabetesStuart J McGurnaghan, Paul M McKeigue, Stephanie H Read, et al.
BMJ Open|October 12, 2022
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in ScotlandStuart J McGurnaghan, Luke A K Blackbourn, Thomas M Caparrotta, et al.
Diabetologia|May 27, 2020
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017Joseph E O'Reilly, Luke A K Blackbourn, Thomas M Caparrotta, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Hypertension (Dallas, Tex. : 1979)|July 30, 2024
<i>UMOD</i> Genotype-Blinded Trial of Ambulatory Blood Pressure Response to TorasemideLinsay McCallum, Stefanie Lip, Alex McConnachie, et al.
Plos Medicine|October 20, 2020
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control studyPaul M McKeigue, Amanda Weir, Jen Bishop, et al.
Diabetologia|January 12, 2019
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational studyStuart J McGurnaghan, Liam Brierley, Thomas M Caparrotta, et al.
BMC Medicine|February 22, 2021
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control studyPaul M McKeigue, Sharon Kennedy, Amanda Weir, et al.
Diabetologia|February 20, 2021
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetesAndreas Höhn, Anita Jeyam, Thomas M Caparrotta, et al.
Eclinicalmedicine|July 19, 2019
Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol OverdoseJanice M Pettie, Thomas M Caparrotta, Robert W Hunter, et al.
Diabetologia|October 7, 2021
Flash monitor initiation is associated with improvements in HbA<sub>1c</sub> levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational studyAnita Jeyam, Fraser W Gibb, John A McKnight, et al.
Diabetologia|June 9, 2021
Development and validation of a cardiovascular risk prediction model in type 1 diabetesStuart J McGurnaghan, Paul M McKeigue, Stephanie H Read, et al.
BMJ Open|October 12, 2022
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in ScotlandStuart J McGurnaghan, Luke A K Blackbourn, Thomas M Caparrotta, et al.
Diabetologia|May 27, 2020
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017Joseph E O'Reilly, Luke A K Blackbourn, Thomas M Caparrotta, et al.
Pageof 3